Published • loading... • Updated
IGC Pharma (NYSE: IGC) CEO and CFO Acquire More Than 4.2 Million Shares
- IGC Pharma CEO Ram Mukunda acquired 2,226,475 shares by cancelling about $601,148 of debt owed to him, increasing his total ownership to 6,875,563 shares.
- CFO Claudia Grimaldi acquired 2,048,378 shares by cancelling around $553,062 of debt owed to her, raising her total shares to 3,421,092.
- The shares were acquired by both executives through debt-for-equity transactions at approximately $0.27 per share.
- IGC Pharma is advancing a Phase 2 clinical trial for an Alzheimer's agitation drug and expanding its AI platform for drug discovery.
Insights by Ground AI
101 Articles
101 Articles
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources101
Leaning Left9Leaning Right10Center46Last UpdatedBias Distribution71% Center
Bias Distribution
- 71% of the sources are Center
71% Center
14%
C 71%
15%
Factuality
To view factuality data please Upgrade to Premium
